English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  CD74-NRG1 fusions in lung adenocarcinoma

Fernandez-Cuesta, L., Plenker, D., Osada, H., Sun, R., Menon, R., Leenders, F., et al. (2014). CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discovery, 4(4), 415-422. doi:10.1158/2159-8290.CD-13-0633.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Fernandez-Cuesta, Lynette1, Author           
Plenker, Dennis2, Author
Osada, Hirotaka2, Author
Sun, Ruping2, Author
Menon, Roopika2, Author
Leenders, Frauke2, Author
Ortiz-Cuaran, Sandra2, Author
Peifer, Martin3, Author           
Bos, Marc2, Author
Daßler, Juliane2, Author
Malchers, Florian3, Author           
Schöttle, Jakob1, Author           
Vogel, Wenzel2, Author
Dahmen, Ilona2, Author
Koker, Mirjam3, Author           
Ullrich, Roland T.1, Author           
Wright, Gavin M.2, Author
Russell, Prudence A.2, Author
Wainer, Zoe2, Author
Solomon, Ben2, Author
Brambilla, Elisabeth2, AuthorNagy-Mignotte, Helene2, AuthorMoro-Sibilot, Denis2, AuthorBrambilla, Christian G.2, AuthorLantuejoul, Sylvie2, AuthorAltmüller, Janine2, AuthorBecker, Christian2, AuthorNürnberg, Peter2, AuthorHeuckmann, Johannes M.3, Author           Stoelben, Erich2, AuthorPetersen, Iver2, AuthorClement, Joachim H.2, AuthorSänger, Jörg2, AuthorMuscarella, Lucia A.2, Authorla Torre, Annamaria2, AuthorFazio, Vito M.2, AuthorLahortiga, Idoya2, AuthorPerera, Timothy2, AuthorOgata, Souichi2, AuthorParade, Marc2, AuthorBrehmer, Dirk2, AuthorVingrom, Martin2, AuthorHeukamp, Lukas C.2, AuthorBuettner, Reinhard2, AuthorZander, Thomas1, Author           Wolf, Johanna2, AuthorPerner, Sven2, AuthorAnsen, Sascha2, AuthorHaas, Stefan A.2, AuthorYatabe, Yasushi2, AuthorThomas, Roman K.3, Author            more..
Affiliations:
1Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
2a Department of Translational Genomics, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany b Department I of Internal Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany c Laboratory of Translational Cancer Genomics, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany d Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany e Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany f Cologne Center for Genomics (CCG), University of Cologne, Germany g Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany h Department of Pathology, University Hospital Medical Center, University of Cologne, Germany i Blackfield AG, Germany j Thoracic Surgery, Lungenklinik Merheim, Kliniken der Stadt Köln gGmbH, Cologne, Germany k Institute of Human Genetics, Cologne, Germany l Computational Molecular Biology Department, Max Planck Institute for Molecular Genetics, Berlin, Germany m Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn, Bonn, Germany n Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany o Institute of Pathology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany p Department of Internal Medicine II, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany q Institute for Pathology Bad Berka, Bad Berka, Germany r Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan s Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan t Departments of Surgery, St. Vincent's Hospital, Australia u Departments of Pathology, St. Vincent's Hospital, Australia v Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia w Department of Pathology, Grenoble-Alpes University, Grenoble, France x CHU Grenoble Institut National de la Santé et de la Recherche Medicale (INSERM) U823, Institute Albert Bonniot, Grenoble-Alpes University, Grenoble, France y Laboratory of Oncology IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy aa Laboratory for Molecular Medicine and Biotechnology, University Campus Bio-Medico, Rome, Italy ab Center for the Biology of Disease, VIB, Leuven, Belgium ac Oncology Discovery, Janssen Research and Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium, ou_persistent22              
3Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              

Content

show
hide
Free keywords: -
 Abstract: © 2014 American Association for Cancer Research.

Details

show
hide
Language(s): eng - English
 Dates: 2014
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 695280
DOI: 10.1158/2159-8290.CD-13-0633
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cancer Discovery
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 4 (4) Sequence Number: - Start / End Page: 415 - 422 Identifier: ISSN: 21598290S